Profile | GDS5420 / 231535_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 28.09 | 23 |
GSM1296119 | B_lesional_pre-dose | 205.68 | 52 |
GSM1296076 | C_lesional_pre-dose | 206.53 | 54 |
GSM1296092 | D_lesional_pre-dose | 358.68 | 63 |
GSM1296103 | E_lesional_pre-dose | 71.82 | 37 |
GSM1296078 | F_lesional_pre-dose | 68.61 | 36 |
GSM1296107 | G_lesional_pre-dose | 146.74 | 46 |
GSM1296109 | H_lesional_pre-dose | 38.88 | 25 |
GSM1296080 | I_lesional_pre-dose | 34.43 | 27 |
GSM1296090 | J_lesional_pre-dose | 522.54 | 69 |
GSM1296074 | K_lesional_pre-dose | 112.69 | 46 |
GSM1296111 | L_lesional_pre-dose | 95.2 | 38 |
GSM1296099 | M_lesional_pre-dose | 162.21 | 49 |
GSM1296086 | O_lesional_pre-dose | 319.52 | 61 |
GSM1296117 | P_lesional_pre-dose | 83.59 | 36 |
GSM1296113 | Q_lesional_pre-dose | 75.12 | 33 |
GSM1296096 | R_lesional_pre-dose | 156.67 | 49 |
GSM1296105 | S_lesional_pre-dose | 224.47 | 53 |
GSM1296098 | T_lesional_pre-dose | 32.69 | 21 |
GSM1296101 | U_lesional_pre-dose | 127.79 | 45 |
GSM1296121 | V_lesional_pre-dose | 113.23 | 42 |
GSM1296088 | W_lesional_pre-dose | 100.46 | 42 |
GSM1296082 | X_lesional_pre-dose | 100.28 | 43 |
GSM1296115 | Y_lesional_pre-dose | 198.14 | 52 |
GSM1296084 | Z_lesional_pre-dose | 490.21 | 67 |
GSM1296072 | B_lesional_day8 | 348.46 | 61 |
GSM1296069 | L_lesional_day8 | 204.81 | 51 |
GSM1296071 | P_lesional_day8 | 188.81 | 49 |
GSM1296070 | Y_lesional_day8 | 271.62 | 56 |
GSM1296073 | V_lesional_day8 | 91.05 | 39 |
GSM1296034 | A_lesional_day15 | 33.36 | 24 |
GSM1296041 | G_lesional_day15 | 51.5 | 29 |
GSM1296035 | R_lesional_day15 | 112.9 | 44 |
GSM1296038 | U_lesional_day15 | 245.83 | 56 |
GSM1296047 | B_lesional_day15 | 504.33 | 68 |
GSM1296039 | E_lesional_day15 | 179.18 | 51 |
GSM1296042 | H_lesional_day15 | 77.56 | 35 |
GSM1296043 | L_lesional_day15 | 205.42 | 51 |
GSM1296037 | M_lesional_day15 | 1068.68 | 80 |
GSM1296046 | P_lesional_day15 | 267.63 | 56 |
GSM1296044 | Q_lesional_day15 | 168.06 | 47 |
GSM1296045 | Y_lesional_day15 | 384.73 | 63 |
GSM1296025 | C_lesional_day15 | 268.51 | 58 |
GSM1296033 | D_lesional_day15 | 685.28 | 73 |
GSM1296027 | I_lesional_day15 | 439.67 | 66 |
GSM1296032 | J_lesional_day15 | 1130.62 | 81 |
GSM1296024 | K_lesional_day15 | 238.85 | 56 |
GSM1296031 | W_lesional_day15 | 439.19 | 65 |
GSM1296028 | X_lesional_day15 | 583.11 | 70 |
GSM1296029 | Z_lesional_day15 | 489.68 | 67 |
GSM1296026 | F_lesional_day15 | 18.96 | 16 |
GSM1296030 | O_lesional_day15 | 357.43 | 63 |
GSM1296040 | S_lesional_day15 | 59.11 | 33 |
GSM1296036 | T_lesional_day15 | 39.26 | 26 |
GSM1296048 | V_lesional_day15 | 109.09 | 42 |
GSM1296059 | A_lesional_day43 | 83.65 | 40 |
GSM1296066 | G_lesional_day43 | 121.59 | 42 |
GSM1296060 | R_lesional_day43 | 240.55 | 55 |
GSM1296063 | U_lesional_day43 | 145.07 | 47 |
GSM1296064 | E_lesional_day43 | 172.56 | 51 |
GSM1296067 | H_lesional_day43 | 89.04 | 37 |
GSM1296062 | M_lesional_day43 | 286.39 | 58 |
GSM1296068 | Q_lesional_day43 | 307.55 | 58 |
GSM1296050 | C_lesional_day43 | 552.69 | 70 |
GSM1296057 | D_lesional_day43 | 674.76 | 72 |
GSM1296052 | I_lesional_day43 | 339.82 | 62 |
GSM1296054 | J_lesional_day43 | 627.84 | 71 |
GSM1296049 | K_lesional_day43 | 238.69 | 56 |
GSM1296055 | W_lesional_day43 | 281.6 | 57 |
GSM1296053 | X_lesional_day43 | 348.05 | 61 |
GSM1296058 | Z_lesional_day43 | 448.01 | 66 |
GSM1296051 | F_lesional_day43 | 280.51 | 59 |
GSM1296056 | O_lesional_day43 | 149.33 | 49 |
GSM1296065 | S_lesional_day43 | 303.78 | 59 |
GSM1296061 | T_lesional_day43 | 62.34 | 33 |
GSM1296095 | A_non-lesional_pre-dose | 82.9 | 39 |
GSM1296120 | B_non-lesional_pre-dose | 534.74 | 69 |
GSM1296077 | C_non-lesional_pre-dose | 499.76 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 410.24 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 574.06 | 70 |
GSM1296079 | F_non-lesional_pre-dose | 195.36 | 53 |
GSM1296108 | G_non-lesional_pre-dose | 274.61 | 57 |
GSM1296110 | H_non-lesional_pre-dose | 124.22 | 42 |
GSM1296081 | I_non-lesional_pre-dose | 354.26 | 62 |
GSM1296091 | J_non-lesional_pre-dose | 1401.66 | 84 |
GSM1296075 | K_non-lesional_pre-dose | 466.64 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 391.64 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 1255.24 | 83 |
GSM1296087 | O_non-lesional_pre-dose | 1046.54 | 79 |
GSM1296118 | P_non-lesional_pre-dose | 956.47 | 79 |
GSM1296114 | Q_non-lesional_pre-dose | 211.32 | 52 |
GSM1296097 | R_non-lesional_pre-dose | 301.79 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 286.61 | 57 |
GSM1296102 | U_non-lesional_pre-dose | 263.9 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 208.82 | 52 |
GSM1296089 | W_non-lesional_pre-dose | 438.29 | 65 |
GSM1296083 | X_non-lesional_pre-dose | 140.73 | 47 |
GSM1296116 | Y_non-lesional_pre-dose | 466.7 | 66 |
GSM1296085 | Z_non-lesional_pre-dose | 1051.44 | 80 |